German biotech company BioNTech , which has approval for human trials of potential coronavirus vaccines, has lately received several approaches about a possible takeover but has rejected them, a newspaper reported on Saturday.
FILE PHOTO: The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany July 31, 2018. REUTERS/Ralph Orlowski
BERLIN - BioNTech chief Ugur Sahin said the company had been approached by several players in the industry, Welt am Sonntag newspaper quoted him as saying, without identifying any of the potential interested parties. “Takeovers are out of the question for the majority shareholders and for us anyway. Our vision is to build a biopharmaceutical company that addresses the medical needs of the 21st century,” Sahin told the newspaper.Earlier this week, shares in BioNTech soared after Germany gave the green light for human trials of potential coronavirus vaccines it is developing with Pfizer .
BioNTech said it was developing four vaccine candidatesunder a programme with Pfizer named BNT162 in what is the fourth trial worldwide of a vaccine targeting the virus.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cartels, crime rings exploit supply shortages during COVID-19 pandemic, authorities sayA volunteer group associated with a company owned by El Chapo's daughter has been handing out essentials during the COVID-19 pandemic.
Read more »
America’s dry run to defend Europe is derailed by covid-19The European Commission’s latest budget proposal could shrink funds for military mobility from €6.5bn ($7.1bn) to zero
Read more »
Covid-19 exposes flaws in Britain’s good-times governmentBoris Johnson promised prosperity and levity. Now he just hopes to deliver enough virus tests
Read more »